Intellectual Property India Publishes Patent Application for Crispr-Cas9 Gene Editing For Insulin Restoration In Pancreatic Beta Cells

MUMBAI, India, July 31 -- Intellectual Property India has published a patent application (202411096002 A) filed by Lovely Professional University on December 05, 2024, for Crispr-Cas9 Gene Editing For Insulin Restoration In Pancreatic Beta Cells.

Inventor includes Yuman.

The application for the patent was published on July 24, 2026, under issue no. 30/2026.

Abstract: A method for CRISPR-Cas9 gene editing comprising introducing a CRISPR-Cas9 system, comprising a Cas9 enzyme and a guide RNA (gRNA) specifically designed to target the INS gene, into pancreatic beta cells. It is delivered using either viral vectors, such as adeno-associated viruses (AAV), or non-viral vectors, such as lipid nanoparticles. The Cas9 enzyme induces a double-stra...